Microbiology FDA 483 (Kilitch Healthcare): Failure to thoroughly review any unexplained discrepancy
Your firm failed to adequately assess the following complaint batches for potential microbial contamination.
Your firm failed to adequately assess the following complaint batches for potential microbial contamination.
Environmental monitoring sampling locations have not been selected considering routine aseptic operations and interventions. Locations for surface monitoring that have
On October 12, 2023, a microbiology manager was observed back dating entries into the “Sterility Test Sample Inward Register”. Other
On October 13, 2023 it was observed during a production area walkthrough that the *** floor in the Grade B
(1) There is no assurance an effective sporicidal is used in the aseptic filling areas. *** *** is done with
(1) Smoke studies do not show demonstrate appropriate airflow:
(a) Smoke studies for Line *** and Line *** show turbulent
Microbiologists responsible for collecting environmental monitoring and personnel monitoring samples confirmed they do not collect all samples due to workload.